Company / Current Assets
PLUS THERAPEUTICS, INC. Current Assets History
FY2011-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$15.2M
FY2025
5-year range
$5.3M / $18.7M
FY2021-FY2025
Trend
+188.5%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $15M to $15M over the past 7 years.
Based on SEC 10-K filings.
$15M in FY2025 with a 10-year CAGR of -3.3%.
Improved from $15M to $15M over the past 7 years.
Current Assets over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -3.3%
Key checks
Key Insights
- In FY2025, current assets increased 188.5% year-over-year.
- Peak current assets was recorded in FY2011.
- Lowest current assets in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score -2.46 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $15.2M | +188.5% |
| FY2024 | $5.3M | -64.6% |
| FY2018 | $14.9M | +0.0% |
| FY2017 | $14.9M | -20.7% |
| FY2016 | $18.7M | -11.7% |
| FY2015 | $21.2M | -2.0% |
| FY2014 | $21.7M | -11.8% |
| FY2013 | $24.6M | -27.7% |
| FY2012 | $34.0M | -42.4% |
| FY2011 | $59.0M | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026